Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
Saved in:
| Title: | Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''. |
|---|---|
| Authors: | Vyse A; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Campling J; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Czudek C; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Ellsbury G; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Mendes D; Health & Value, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Reinert RR; Medical Affairs, Pfizer Inc, Paris, France., Slack MPE; School of Medicine & Dentistry, Griffith University, Gold Coast Campus, Queensland 4222, Australia. |
| Source: | Expert review of vaccines [Expert Rev Vaccines] 2022 Jun; Vol. 21 (6), pp. 871-872. Date of Electronic Publication: 2022 Mar 08. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8395 |
|---|---|
| DOI: | 10.1080/14760584.2022.2047024 |
